ELOX Eloxx Pharmaceuticals, Inc.
$18.76
Eloxx Pharmaceuticals, Inc. (ELOX) is expected to report earnings on November 10, 2026, after the market close.
Eloxx Pharmaceuticals Reported Earnings
Wednesday, August 12, 2026 · 6:00 AM ET
Earnings Date
Nov 10
Tuesday · 4:15 PM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
-
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Eloxx Pharmaceuticals, Inc.
Eloxx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing novel RNA-modulating drug candidates (designed to be eukaryotic ribosomal selective glycosides) that are formulated to treat rare and ultra-rare premature stop codon diseases.
Sector
Healthcare
Industry
Biotechnology